Loading market dashboard

Financials in USD. Standardized financial statements.
A compact view of how Veracyte, Inc. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $517.14M | $445.76M | $361.05M | $296.54M | $219.51M | $117.48M | $120.37M | $92.01M | $71.95M | $65.08M |
| Revenue Growth? | +16.0% | +23.5% | +21.8% | +35.1% | +86.8% | -2.4% | +30.8% | +27.9% | +10.6% | 0.0% |
| Cost of Revenue? | $157.10M | $147.62M | $112.90M | $101.58M | $74.40M | $41.45M | $36.52M | $33.08M | $28.20M | $25.46M |
| Gross Profit? | $360.05M | $298.14M | $248.15M | $194.95M | $145.11M | $76.03M | $83.84M | $58.93M | $43.76M | $39.62M |
| Gross Margin? | +69.6% | +66.9% | +68.7% | +65.7% | +66.1% | +64.7% | +69.7% | +64.0% | +60.8% | +60.9% |
| Operating Expenses? | $285.89M | $282.00M | $333.94M | $236.03M | $227.02M | $111.42M | $98.97M | $81.16M | $70.30M | $68.43M |
| Operating Income? | $74.15M | $16.14M | -$85.80M | -$41.08M | -$81.90M | -$35.39M | -$15.13M | -$22.23M | -$26.54M | -$28.80M |
| EBITDA? | $89.62M | $49.20M | -$49.41M | -$6.98M | -$60.18M | -$26.74M | -$7.80M | -$17.12M | -$23.76M | -$25.09M |
| Income Before Tax | $68.20M | $25.74M | -$76.61M | -$36.43M | -$81.65M | -$34.91M | -$12.60M | -$23.00M | -$31.00M | -$31.36M |
| Income Tax Expense | $1.85M | $1.61M | -$2.21M | $133,000 | -$6.09M | $0 | $0 | $0 | $0 | $0 |
| Net Income? | $66.35M | $24.14M | -$74.40M | -$36.56M | -$75.56M | -$34.91M | -$12.60M | -$23.00M | -$31.00M | -$31.36M |
| EPS? | $0.84 | $0.32 | $-1.02 | $-0.51 | $-1.11 | $-0.66 | $-0.27 | $-0.62 | $-0.91 | $-1.09 |
| Diluted EPS? | $0.82 | $0.31 | $-1.02 | $-0.51 | $-1.11 | $-0.66 | $-0.27 | $-0.62 | $-0.91 | $-1.09 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality